Event dossier

Eli Lilly CEO says 700,000 new seniors have started GLP-1s after Medicare coverage, and 70% are on Lilly drugs

They're the latest metrics on how much the new Medicare coverage is expanding access to GLP-1 medicines since it launched in July. Grouped from 2 articles across 1 sources.

2 reports1 sourceSep 21, 2026, 7:37 PM
FilterCNBC
Clustered coverageCNBC
Coverage timeline2
Coverage timeline

Coverage timeline

Ranked reports inside the event cluster. Open any publisher link to read the original coverage.

CNBCSep 21, 2026, 7:37 PM

Eli Lilly CEO says 700,000 new seniors have started GLP-1s after Medicare coverage, and 70% are on Lilly drugs

They're the latest metrics on how much the new Medicare coverage is expanding access to GLP-1 medicines since it launched in July.

CNBCSep 21, 2026, 6:57 PM

Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production

Eli Lilly is trying to catch up in the GLP-1 pill market to Novo, which got a head start in the space.

Related events

Related events

Nearby clusters pulled from title, summary, and keyword similarity in PostgreSQL.